PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.94
Similar ESG score to FBIO's 58.40. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
54.17
Environmental score 1.1-1.2x FBIO's 48.71. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
56.72
Social score 90-95% of FBIO's 62.77. Bill Ackman would demand clear social improvement catalysts.
56.94
Governance score 80-90% of FBIO's 63.72. Walter Schloss would scrutinize management accountability and board independence.